First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers.
Autor: | Van Eldik, Linda J.1,2,3 (AUTHOR) linda.vaneldik@uky.edu, Sawaki, Lumy4 (AUTHOR), Bowen, Karen5 (AUTHOR), Laskowitz, Daniel T.6,7 (AUTHOR), Noveck, Robert J.8 (AUTHOR), Hauser, Byron8 (AUTHOR), Jordan, Lynn8 (AUTHOR), Spears, Tracy G.7 (AUTHOR), Wu, Huali7 (AUTHOR), Watt, Kevin7 (AUTHOR), Raja, Shruti6,8 (AUTHOR), Roy, Saktimayee M.9 (AUTHOR), Watterson, D. Martin9 (AUTHOR), Guptill, Jeffrey T.6,7,8 (AUTHOR) |
---|---|
Zdroj: | Clinical Pharmacology in Drug Development. Feb2021, Vol. 10 Issue 2, p131-143. 13p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |